semaglutide patent protection No Generics Approved in China One Month After Expiry Brazilian federal court denies semaglutide

CVS Caremark announced on May 1, 2025 that AOM tirzepatide (sold as Zepbound) would be removed from its standard preferred formulary effective July 1, 2025 ( 2 , 3 )

In the early 1990s, scientists observed that there was a toxin found in Gila monster saliva which caused its prey to develop low blood sugars (hypoglycemia), making them an easy, tasty treat

Phentermine is an FDA-approved appetite suppressant that can help reduce hunger, increase energy, and boost metabolism

Thyroid function can downregulate

January 19, 2025: Important Trial Date Set in Group Ozempic Lawsuit Many people who were harmed by Ozempic have joined the group lawsuit for GLP-1 drugs (MDL 3094: GLP-1 Products Liability Litigation)